![](/img/cover-not-exists.png)
P32 Abatacept demonstrates consistent safety and sustained improvements in efficacy through 5 years of treatment in biologic-naïve patients with RA
Gregory Macaraeg, JM Kremer, AS Russell, P Emery, C Abud-Mendoza, J Szechinski, JC Becker, G Wu, R WesthovensVolume:
4
Year:
2009
Language:
english
DOI:
10.1016/s0973-3698(09)60050-9
File:
PDF, 88 KB
english, 2009